ACTRN12613000562774已完成未知
Renal endoluminal denervation to reduce sympathetic overdrive in dialysis-dependent patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 8 Years 至 o limit（—）
- 性别
- All
入选标准
- •Age > 18 and able to give consent.
- •On dialysis for at least 3 months.
- •Clinically stable with no evidence of fluid overload, recent myocardial ischaemia or heart attack.
- •Blood pressure > 130/90 despite medications.
- •They must have intact native renal kidneys
排除标准
- •Patients with significant renovascular abnormalities will not permitted to undergo the intervention. Anatomic abnormalities including multiple main renal arteries, short length main renal arteries, failed renal transplant, are exclusion criteria.
- •Inability to give consent.
研究者
相似试验
撤回
不适用
Sympathy Redo: redo of renal denervation with a second generation device.hypertensiehigh blood pressure10038430hypertensionNL-OMON42639niversitair Medisch Centrum Utrecht30
已完成
3 期
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension.hypertensiehigh blood pressure10038430hypertensionNL-OMON39831niversitair Medisch Centrum Utrecht570
撤回
不适用
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension: from rescue to resolve.hoge bloeddrukhypertension high blood pressure10038430NL-OMON37568niversitair Medisch Centrum Utrecht260
招募中
不适用
Renal denervation to improve heart failureSystolic heart failureNL-OMON25325Erasmus Medical CenterRotterdam, the Netherlands70
招募中
不适用
Endovascular Renal Sympathetic Denervation using the Boston Scientific Vessix V2 renal denervation system to Improve Heart Failure10019280Heart failureNL-OMON40689Erasmus MC, Universitair Medisch Centrum Rotterdam70